HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Item
http://www.wikidata.org/entity/Q26782405
Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral AgentsIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by HCV genotype 1b infection: Real world data.Current challenges and possible solutions to improve access to care and treatment for hepatitis C infection in Vietnam: a systematic review.Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.Resistance Characterization of Hepatitis C Virus Genotype 2 from Japanese Patients Treated with Ombitasvir and Paritaprevir/Ritonavir.A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors.Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A-Y93.
P2860

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Item
http://www.wikidata.org/entity/Q26782405
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@ast
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@en
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@nl
type
label
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@ast
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@en
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@nl
prefLabel
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@ast
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@en
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
HCV Drug Resistance Challenges ...... irect Acting Antiviral Therapy
@en
P2093
P275
P2860
P304
P31
P3181
P356
P407
P433
P478
P577
P5875
P698
P921
P932